Targeted inhibition of glutamine metabolism enhances the antitumor effect of selumetinib in KRAS-mutant NSCLC
Xia, Meng, Li, Xuena, Diao, Yao, Du, Bulin, Li, YamingVolume:
14
Journal:
Translational Oncology
DOI:
10.1016/j.tranon.2020.100920
Date:
January, 2021
File:
PDF, 242 KB
2021